Kidney disease is one of the leading complications of diabetes, and can lead to serious health problems, including the need for dialysis or kidney transplant. Despite many medical advances that have improved diabetes treatment, kidney disease remains a problem for many people with diabetes. New treatments are urgently needed.

PERL is a clinical trial for people with type 1 diabetes who have early signs of kidney problems. Our goal is to test a new way to reduce loss of kidney function using a safe and inexpensive medicine. We are seeking adults with type 1 diabetes to participate in our study.

Find out more about our study and whether you might be eligible and how you can participate.